Daniel Burkhoff and Akshay Desai discuss the innovative technologies and late-breaking science presented at day 2 of THT.
The findings suggest clinicians don’t need to be as aggressive in lowering BP in this population, at least early after ...
Amid late-breaking coronary, structural, and endovascular trials will be a keynote from President Biden, and more.
Patients already had high NT-proBNP levels at baseline, though, raising questions about the quality of GDMT, Nancy Sweitzer ...
The study emphasizes the importance of vigilance with diet and exercise, among other things, to reduce CV risk in type 2 diabetes.
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...
The approach could help clinicians who are “burdened with information overload” manage their patients, one expert says.
It may seem overwhelming, but committee chair Karen Joynt Maddox says small changes may help turn things around.
Cath labs require trust to bring out the best in teams and patient outcomes. Interventionalists, as leaders, set the tone.
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results